Problems › What Should We Do Next Quarter? › Professional Services
Most quarterly plans fail on capacity arithmetic rather than on choice of priorities. This page works through it for professional services firms specifically — including an unedited excerpt from a real analysis of a professional services firm.
Most quarterly plans fail on capacity arithmetic rather than on choice of priorities. Professional services firms carry a specific bind here — partner compensation rationally pays people not to sell the highest-margin product in the firm. Until that is priced, billable utilisation will keep moving for reasons nobody can attribute, and the debate about return per initiative will stay a matter of opinion.
A quarter contains a fixed amount of management attention and a fixed amount of cash, and most plans commit more of both than exist. The result is not failure but silent triage: the organisation does the subset it can and nobody records which parts were dropped.
A plan that survives contact ranks candidate moves by return, checks each against the capacity actually available, and sequences them so the first funds or unblocks the second. Three real priorities beat twelve stated ones every time.
The part almost always missing is the stopping rule — the observation that would say a chosen move is not working, defined before it starts rather than argued about afterwards.
These three together are the signature. One on its own usually points somewhere else.
✓ Last quarter's plan was partly done and nobody formally dropped anything
✓ Priorities are listed but not ranked
✓ No initiative has a written failure condition
The move that usually makes it worse. Committing to everything that seems important, which guarantees the organisation chooses for you and chooses by convenience.
It is for you if you run or finance a professional services firm and last quarter's plan was partly done and nobody formally dropped anything. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a professional services firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Re-align partner economics so the $85K diagnostic becomes the highest-compensated path to the $410K implementation.
The leak it closes. Partner-level incentive leakage that currently diverts 25% of diagnostic-eligible opportunities back to T&M work
The assumption it rests on. 15-of-22 partners approve compensation redesign within 60 days — the engine put the probability at 0.7.
| Investment required | $700K total over 36 months — $200K annual incentive pool × 3 years + $100K legal and change-management cost |
| Expected return | 3.4× cash-on-cash over 36 months (NPV $2.4M / $700K investment) on $58.0M current revenue base |
| Revenue, year 1 | +$1.2M incremental diagnostic and implementation revenue (15 additional diagnostics × $85K + 12 conversions × $410K) |
| Revenue, year 2 | +$2.4M cumulative incremental revenue |
| Revenue, year 3 | +$3.7M cumulative incremental revenue |
| Exit criteria | Terminate this move and revert to legacy compensation if (a) fewer than 12-of-22 partners approve redesign by Day 60, or (b) any top-3 account issues an RFP within 90 days of announcement, or (c) diagnostic-to-implementation conversion falls below 10-of-19 by December 31, 2026. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For professional services firms it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
As many as your real capacity supports, which in most small and mid-sized businesses is two or three. The number is arithmetic, not philosophy.
Rank by return on the capacity each consumes, then by reversibility. When two are close, do the one you can stop.
That is what the stopping rules are for. A plan with pre-agreed failure conditions can be changed on evidence rather than on argument, which is the difference between adapting and drifting.
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.